SCHEMBL7616636

SCHEMBL7616636

CC(C)c1cc(CO[Si](C)(C)C(C)(C)C)cc(C(C)C)c1N

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.32
P2RX3 P56373 1/20 0.31
P2RX2 Q9UBL9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25239402 0.78 POLB (0.39)
SCHEMBL18924077 0.78 DUT (0.32)
SCHEMBL19000562 0.74 APLNR (0.34)
SCHEMBL6249636 0.73
SCHEMBL25001123 0.73 DRD2 (0.35) P2RX3P2RX2
SCHEMBL19000567 0.73 IDO1 (0.33)
SCHEMBL17615243 0.72 LOXL2 (0.30)
SCHEMBL6301535 0.72 ALDH1A1 (0.40)
SCHEMBL1933709 0.72
SCHEMBL22198892 0.72 BACE1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420381-B1 ACYL-COA: CHOLESTEROL ACYL TRANSFERASE (ACAT) INHIBITORY ACTIVITY, AND IS USEFUL AS AN AGENT FOR TREATMENT OF HYPERLIPIDEMIA AND ATHEROSCLEROSIS. SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2002-07-16 US disclosed
EP-1104763-A1 NAPHTHYRIDINE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-06-06 EP disclosed